Abstract:Most therapies for treating sensorineural hearing loss are challenged by the delivery across multiple tissue barriers to the hard-to-access anatomical location of the inner ear. In this review, we will provide a recent update on various pharmacotherapy, gene therapy, and cell therapy approaches used in clinical and preclinical studies for the treatment of sensorineural hearing loss and approaches taken to overcome the drug delivery barriers in the ear. Small-molecule drugs for pharmacotherapy can be delivered via systemic or local delivery, where the blood-labyrinth barrier hinders the former and tissue barriers including the tympanic membrane, the round window membrane, and/or the oval window hinder the latter. Meanwhile, gene and cell therapies often require targeted delivery to the cochlea, which is currently achieved via intra-cochlear or intra-labyrinthine injection. To improve the stability of the biomacromolecules during treatment, e.g., RNAs, DNAs, proteins, additional packing vehicles are often required. To address the diverse range of biological barriers involved in inner ear drug delivery, each class of therapy and the intended therapeutic cargoes will be discussed in this review, in the context of delivery routes commonly used, delivery vehicles if required (e.g., viral and non-viral nanocarriers), and other strategies to improve drug permeation and sustained release (e.g., hydrogel, nanocarriers, permeation enhancers, and microfluidic systems). Overall, this review aims to capture the important advancements and key steps in the development of inner ear therapies and delivery strategies over the past two decades for the treatment and prophylaxis of sensorineural hearing loss.

Drug Delivery Across Barriers to the Middle and Inner Ear.

Cutting‐Edge Achievements of Inner Ear Drug Delivery Systems

Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives

Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities

Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials

Localized drug delivery to the middle ear: Recent advances and perspectives for the treatment of middle and inner ear diseases

Development of Novel Drug Carrier Via Round Window Membrane

Treating Sensorineural Hearing Loss: Recent Advances in Inner Ear Drug Delivery

Application of Nanomedicine in Inner Ear Diseases

Nanoparticle-based inner ear delivery systems for the treatment of hearing loss

Nanocarriers for Inner Ear Disease Therapy

Drug delivery systems for the treatment of sensorineural hearing loss

Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear

Improved intracochlear biopolymeric drug delivery system: an in vivo study

The Progress of Topical Drug Delivery to the Inner Ear for the Inhibition of Inflammation and Fibrosis Following Cochlear Implantation

Magnetic/Acoustic Dual-Controlled Microrobot Overcoming Oto-Biological Barrier for On-Demand Multidrug Delivery against Hearing Loss

Enhancement of Bioavailability and Bioequivalence of Drug Delivery in Sensory Neural Hearing Loss

Mastoid approach for local drug delivery to the inner ear for treating hearing loss

Reversible opening of the blood-labyrinth barrier by low-pressure pulsed ultrasound and microbubbles for the treatment of inner ear diseases

Recent Advances and Future Research Directions for Hearing Loss Treatment Based on Nanoparticles

Semicircular canal drug delivery safely targets the inner ear perilymphatic space